Quadrise PLC (AIM:QED) has told investors that agreements with MSC and Cargill to start commercial-scale marine evaluations are close to completion.
Meanwhile, installation of trial equipment at the MAC2 site in Antwerp is due before work begins in the third quarter of 2025.
At the same time, in Morocco, trial equipment for the planned MSAR® test with OCP has been deployed. A 30-day paid trial will begin once approval is received from the original equipment manufacturer, also expected in the third quarter of 2025.
And, in Panama, a trial in Panama with Sparkle Power SA is also planned to get underway in the third quarter. This test will be the company’s first on a MAN 4-stroke diesel engine.
"Quadrise has continued to make progress throughout 2025 to date,” Quadrise chair Andy Morrison said in a statement.
“Whilst some developments have taken longer than originally anticipated, we are more convinced than ever in the strength of our technology, the scale of the opportunity, and our ability to successfully deliver on our strategy.
"We enter the next quarter with real momentum and expect to achieve several important operational milestones which will bring us significantly closer to commercial deployment and long-term value creation for our shareholders."
Quadrise noted that the development of bioMSAR and bioMSAR Zero is ongoing, with several other joint development, commercial discussions, and potential partnerships advancing.
Also, in Utah, Quadrise said it is awaiting new oil samples from Valkor’s site in Utah, USA.
A 600-barrel-per-day Multifuel Manufacturing Unit is due for delivery in the third quarter.
A US$75,000 per quarter technology transfer fee will be payable by Valkor upon delivery.